Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002201668 | SCV002494372 | likely benign | not provided | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002363716 | SCV002623659 | likely benign | Cardiovascular phenotype | 2019-09-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002500438 | SCV002809467 | likely benign | Gallbladder disease 4; Sitosterolemia 1 | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003331330 | SCV004038849 | likely benign | not specified | 2023-08-01 | criteria provided, single submitter | clinical testing |